Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methylene blue, Mycophenolic acid, Posaconazole, and Niclosamide inhibit SARS-CoV-2 Omicron variant BA.1 infection of human airway epithelial organoids
Romain Volle, Luca Murer, Anthony Petkidis, et al.
Current Research in Microbial Sciences (2022) Vol. 3, pp. 100158-100158
Open Access | Times Cited: 10

Showing 10 citing articles:

A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
Anthony Petkidis, Vardan Andriasyan, Luca Murer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2
Mengyuan Wu, Kun Wang, Huiqiang Wang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Activated blood-derived human primary T cells support replication of HAdV C5 and virus transmission to polarized human primary epithelial cells
Daniela Sequeira, Maarit Suomalainen, Patrick C. Freitag, et al.
Journal of Virology (2025)
Open Access
Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs
Jaroslav Pelisek, Benedikt Reutersberg, Urs F. Greber, et al.
Clinical Science (2022) Vol. 136, Iss. 21, pp. 1571-1590
Open Access | Times Cited: 17
Application of methylene blue for the prevention and treatment of COVID-19: A narrative review.
Elaheh Emadi, Daryoush Hamidi Alamdari, Davood Attaran, et al.
PubMed (2024) Vol. 27, Iss. 7, pp. 780-792
Closed Access | Times Cited: 3
Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147
Zhe Yang, Qi Zhang, Xiaoqing Wu, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2019-2019
Open Access | Times Cited: 6
Anthracyclines inhibit SARS-CoV-2 infection
Zhen Wang, Qinghua Pan, Ling Ma, et al.
Virus Research (2023) Vol. 334, pp. 199164-199164
Open Access | Times Cited: 5
Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147
Zhe Yang, Qi Zhang, Xiaoqing Wu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Ex vivo challenge models for infectious diseases
Bhavna G. Gordhan, Dale Liebenberg, Gabriella Scarlatti, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 785-804
Closed Access | Times Cited: 1
Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo
Xiao Yu, Ling Wang, Shisong Fang, et al.
Virology (2023) Vol. 586, pp. 105-114
Open Access
Page 1

Scroll to top